Gandhi Balaji
Known title: Chief Financial OfficerCIK: 0001970527
Associated companies
Transaction History
| PHR | ▲ Buy | Grant | 192,000 | $0 | 9/1/2026 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 25,382 | $232K | 4/9/2026 | View on chart |
| PHR | ▲ Buy | Grant | 35,573 | — | 4/6/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 3,829 | $43K | 3/25/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 4,687 | $77K | 1/16/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 975 | $16K | 1/15/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 8,009 | $136K | 1/8/2026 | View on chart |
| PHR | ▲ Buy | Grant | 66,000 | $0 | 12/5/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 885 | $20K | 10/17/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 4,183 | $97K | 9/16/2025 | View on chart |
| PHR | ▲ Buy | Grant | 6,230 | — | 9/11/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 9,583 | $288K | 8/25/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 886 | $24K | 7/17/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 864 | $21K | 4/16/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 4,916 | $115K | 4/8/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 3,129 | $77K | 4/8/2025 | View on chart |
| PHR | ▲ Buy | Grant | 12,865 | — | 4/4/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 1,827 | $50K | 3/26/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 96 | $3K | 2/19/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 5,771 | $173K | 2/18/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 4,889 | $147K | 2/14/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 28,759 | $863K | 2/13/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 3,360 | $91K | 1/27/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 1,453 | $41K | 1/27/2025 | View on chart |
| PHR | ▲ Buy | Grant | 7,900 | $0 | 1/23/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 5,827 | $159K | 1/21/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 836 | $23K | 1/15/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 3,195 | $85K | 1/6/2025 | View on chart |
| PHR | ▲ Buy | Grant | 53,990 | $0 | 1/2/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 864 | $18K | 10/15/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 3,502 | $81K | 9/10/2024 | View on chart |
| PHR | ▲ Buy | Grant | 5,633 | — | 9/6/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 783 | $19K | 7/16/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 948 | $22K | 4/15/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 78 | $2K | 4/8/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 7,700 | $174K | 4/8/2024 | View on chart |
| PHR | ▲ Buy | Grant | 11,926 | — | 4/5/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 3,504 | $81K | 3/25/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 9,192 | $222K | 1/17/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 932 | $23K | 1/16/2024 | View on chart |
| PHR | ▲ Buy | Grant | 22,000 | $0 | 1/2/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 861 | $14K | 10/16/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 3,799 | $77K | 9/13/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 158 | $3K | 9/13/2023 | View on chart |
| PHR | ▲ Buy | Grant | 6,406 | — | 9/12/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 807 | $27K | 7/14/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 861 | $25K | 7/8/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 2,113 | $67K | 4/17/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 807 | $26K | 4/14/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 2,843 | $86K | 4/10/2023 | View on chart |
| PHR | ▲ Buy | Grant | 4,956 | — | 4/10/2023 | View on chart |
| PHR | ▲ Buy | Grant | 21,428 | $0 | 3/24/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays Raises Phreesia Price Target to $11
Barclays has raised its price target for Phreesia to $11 while maintaining an Equal-Weight rating. This update places the firm's outlook within the broader analyst consensus, which currently averages $14.13. The stock remains well below its 52-week high of $24.07, reflecting a significant drop from previous levels.
Barclays Raises Phreesia Price Target to $11. Barclays has raised its price target for Phreesia to $11 while maintaining an Equal-Weight rating. This update places the firm's outlook within the broader analyst consensus, which currently averages $14.13. The stock remains well below its 52-week high of $24.07, reflecting a significant drop from previous levels.